Tuesday, March 17, 2026

Cultural Invasion: How South Korea Plans to ‘Koreanize’ North Korean Soldiers with Pop Culture

Thae Yong Ho of the People Power Party expressed his strong support for the possibility of resuming loudspeaker broadcasts to North Korea ...

Happy Yum Yum Ramen Shop Launches at Han River Terminals as Part of Ottogi Brand Initiative

Ottogi launches the Happy Yum Yum Ramen Shop at Han River Bus terminals, offering unique dining with stunning views and ramen cooking.

EXO’s Baekhyun Hits New High: Mini-Album Hello, World Tops 1 Million Sales

aekhyun's mini-album Hello, World, released last week, has achieved a remarkable total of 1,096,995 copies sold as of Thursday.

Tag: market

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

Celltrion’s Breakthrough: Why Vegzelma and Herzuma Lead in Japan’s Oncology Market

Celltrion's cancer treatments dominate the Japanese market, with Vegzelma and Herzuma capturing significant shares, showcasing strong growth.

Alteogen Secures U.S. Patent for Keytruda Subcutaneous Injection: What This Means for ALT-B4 and Future Treatments

Alteogen secures a U.S. patent for a subcutaneous Keytruda formulation using ALT-B4, ensuring exclusivity until 2043 and potential $1B in sales.

China Set to Overtake South Korea in OLED Production by 2029

China's OLED production is set to surpass South Korea's by 2029, driven by aggressive investments and growth in display technology.

Celltrion’s Ramucirumab and Infliximab: The Secrets Behind Their Dominance in Oceania’s Biopharmaceutical Market

Celltrion's cancer and autoimmune products are expanding market share in Australia and New Zealand, enhancing influence in Oceania.

Global EV Sales Slip 2.1% in January as Hyundai Motor Group Defies Slowdown

Hyundai Motor shows stable growth in EV sales amid global market decline, driven by diversification strategies and regional performance variations.

How Celltrion’s Herceptin Biosimilar Herzuma Achieved 74% Market Share in Japan: A Game Changer for Cancer Treatment

Celltrion's Herzuma biosimilar captures 74% of Japan's trastuzumab market, enhancing patient access and leveraging favorable policies.

LG Energy Solution Extends Investment Timeline: How Will It Impact EV Market in 2026?

LG Energy Solution is delaying U.S. investments amid EV demand slump and rising rates, extending deadlines to navigate market challenges.

Discover the Future of Aesthetic Treatments: How Nanotechnology is Transforming the Beauty Industry

DongKoo Bio&Pharma partners with Supernova Bio and Areum Medics to innovate aesthetic treatments using advanced nanoparticle technology.

U.S. Buyers Push Hyundai’s Electrified Line to New Record

Hyundai Motor's eco-friendly vehicle sales in the U.S. surpass 1 million, led by hybrids, showing rapid growth in recent years.

Nvidia Shares Slip Amid AI Jitters, but Analysts See Buying Opportunity

Nvidia's stock is undervalued amid AI investment surge, presenting a buying opportunity as tech stocks struggle to recover.

Northwell Health Partners with Rokit Healthcare: What This Means for Skin Cancer Treatment in 2026

Northwell Health partners with Rokit Healthcare to advance skin cancer regeneration and wound healing technologies in the U.S. market.

Limpid Clears U.S. Food and Drug Administration Registration, Targets $54B U.S. Pet Food Market With Freeze-Dried Launch

Bio pet food startup Limpid is set to officially launch its brand in the US market this month after completing preparations.

AI Medical Revolution: Waycen Partners with Dhafir Medical to Launch Waymed Endo in UAE

Waycen partners with Dhafir Medical to introduce AI endoscope in the UAE, enhancing healthcare training and expanding market presence.

Korean Spine-Implant Maker Targets Japan: L&K Biomed Showcases BluEX-LT at the Scoliosis Research Society Meeting

L&K Biomed showcased its products at the SRS conference in Japan, aiming to expand its market share in the APAC region, especially Japan.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.